probiotics / Inf Cancer Research Results

ProBio, probiotics: Click to Expand ⟱
Features:
Probiotics contain live bacteria the supplements the gastrointestinal flora. (Which can be affected from infection or antibiotics drugs.)
Some studies have suggested that gut microbiota—including Bifidobacterium species—can affect systemic immunity. This is important because the state of the immune system influences the body’s ability to fight cancer and also the response to immunotherapies.
Preclinical investigations have demonstrated that certain Bifidobacterium strains may help improve responses to immune checkpoint inhibitors in animal models.
There has been emerging research looking into discrete strains or formulations of Bifidobacterium longum (sometimes labeled with additional identifiers such as RAPO) that may have unique properties or enhanced effects.
Inf, Infection: Click to Expand ⟱
Source:
Type:
An infection occurs when a microorganism—such as a bacterium, virus, fungus, or parasite—enters the body, establishes itself, and begins to multiply.

Oncogenic Viruses and Chronic Infections:
Certain viruses are known as oncogenic (cancer-causing) viruses. For example:
-Human Papillomavirus (HPV): Certain strains of HPV can lead to cervical cancer, as well as other cancers such as oropharyngeal and anal cancers.
-Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV): These viruses can cause chronic liver infections that may progress to liver cirrhosis and ultimately hepatocellular carcinoma (liver cancer).
-Epstein-Barr Virus (EBV): This virus is linked to several cancers, including Hodgkin lymphoma, Burkitt lymphoma, and nasopharyngeal carcinoma.

-Some infections directly or indirectly weaken the immune system, reducing its ability to detect and eliminate emerging cancer cells.
Scientific Papers found: Click to Expand⟱
8117- LA,  ProBio,    The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial
- Trial, CRC, NA
Dose↝, Inf↓, ZO-1↓, other↓,
8118- LA,  ProBio,    Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study
- Trial, CRC, NA
Inf↓, IBI↑, Dose↝, Diar↓,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Transcription & Epigenetics(tgid=7) ⓘ

other↓, 1,  

Migration(tgid=13) ⓘ

ZO-1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

IBI↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 2,  

Infection & Microbiome(tgid=24) ⓘ

Diar↓, 1,   Inf↓, 2,  
Total Targets: 6

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Inf, Infection
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:256  Target#:1241  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page